Bariatric and metabolic surgery during COVID-19 outbreak phase 2 in Italy: why, when and how to restart.
Journal
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
ISSN: 1878-7533
Titre abrégé: Surg Obes Relat Dis
Pays: United States
ID NLM: 101233161
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
06
05
2020
revised:
06
06
2020
accepted:
09
06
2020
pubmed:
3
8
2020
medline:
21
10
2020
entrez:
3
8
2020
Statut:
ppublish
Résumé
In Italy elective bariatric and metabolic surgery was cancelled on February 21,2020 at the beginning of the so-called phase 1 of the SARS-CoV-2 outbreak. Gradually it was restarted on May 4,2020 at the beginning of the so-called phase 2, when epidemiological data showed containment of the infection. Before the outbreak in eight high-volume bariatric centers 840 patients were surgically treated developing a Covid-19 infection, during phase 1, in only 5 cases (0.6%) without mortality. The post-operative complication rate was similar when compared to the 836 subjects submitted to bariatric surgery the year before. Since the high prevalence of infection in subjects with BMI > 30, it was argued that early intervention on obesity during phase 2 could help to minimize the effects of the disease in the event of a possible reversion to a SARS-CoV-2 outbreak phase 1. At the same time a prospective observational study from July 1 till the WHO declaration of the end of the pandemic has started in the eight high volume centers to monitor the post-operative outcome and its effect on SARS-CoV-2 infection.
Identifiants
pubmed: 32739265
pii: S1550-7289(20)30345-2
doi: 10.1016/j.soard.2020.06.025
pmc: PMC7313526
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1614-1618Informations de copyright
Copyright © 2020 American Society for Bariatric Surgery. All rights reserved.
Références
Clin Infect Dis. 2020 Jul 28;71(15):896-897
pubmed: 32271368
Can J Cardiol. 2015 Feb;31(2):153-66
pubmed: 25661550
Health Technol Assess. 1998;2(3):i-iv, 1-88
pubmed: 9561895
Updates Surg. 2020 Jun;72(2):259-268
pubmed: 32514743
Surg Endosc. 2020 Jun;34(6):2327-2331
pubmed: 32323016
Acta Diabetol. 2020 Jun;57(6):759-764
pubmed: 32249357
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Influenza Other Respir Viruses. 2019 Jan;13(1):3-9
pubmed: 30515985
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
Nat Rev Endocrinol. 2020 Jun;16(6):297-298
pubmed: 32242089
J Exp Orthop. 2020 May 13;7(1):28
pubmed: 32405872
BMJ. 2020 May 22;369:m1985
pubmed: 32444460
Obes Surg. 2020 Jun;30(6):2071-2073
pubmed: 32291701
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550
pubmed: 32334646
Arthrosc Sports Med Rehabil. 2020 Apr 27;:
pubmed: 32342047
Br J Surg. 2020 Aug;107(9):e307-e308
pubmed: 32567676
Lancet Diabetes Endocrinol. 2020 Jul;8(7):640-648
pubmed: 32386567
Surg Obes Relat Dis. 2019 Mar;15(3):478-487
pubmed: 30745152
Anaesthesia. 2020 Jul;75(7):928-934
pubmed: 32246838
Lancet. 2016 Aug 20;388(10046):776-86
pubmed: 27423262
J Crit Care. 2020 Aug;58:29-33
pubmed: 32330817
Clin Infect Dis. 2017 Oct 15;65(8):1349-1355
pubmed: 28637274